134 related articles for article (PubMed ID: 24021784)
61. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
62. [Expression and significance of HBV DNA and its 5 antigens in liver cirrhosis].
Wang W; Zhang X; Han H
Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):14-7. PubMed ID: 7781108
[TBL] [Abstract][Full Text] [Related]
63. Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice.
Teng YC; Neo JC; Wu JC; Chen YF; Kao CH; Tsai TF
J Pathol; 2017 Mar; 241(4):463-474. PubMed ID: 27868197
[TBL] [Abstract][Full Text] [Related]
64. Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Balkan A; Namiduru M; Balkan Y; Mete AO; Karaoglan I; Bosnak VK
Saudi J Gastroenterol; 2016; 22(3):208-14. PubMed ID: 27184639
[TBL] [Abstract][Full Text] [Related]
65. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
66. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
67. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
Shi JP; Fan JG; Lou GQ; Zhang L; Hu CB; Wu R; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864
[TBL] [Abstract][Full Text] [Related]
68. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
69. Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
Lian Z; Liu J; Wu M; Wang HY; Arbuthnot P; Kew M; Feitelson MA
Hepatology; 2007 Jun; 45(6):1390-9. PubMed ID: 17539024
[TBL] [Abstract][Full Text] [Related]
70. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
[TBL] [Abstract][Full Text] [Related]
71. [The clinical significance of PreS1Ag and anti-PreS1 in patients with chronic hepatitis B].
Zhang XD; Ren S; Yu HB; Liu YL; Jin Y; Huang YX; Chen JM; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):674-7. PubMed ID: 22152382
[TBL] [Abstract][Full Text] [Related]
72. [Comparative analysis of hepatitis B virus large protein, hepatitis B virus-DNA and Pre-S1 antigen in evaluating serum hepatitis B virus replication].
Xia F; Xu YH; Zheng MJ; Wang XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):501-505. PubMed ID: 28592093
[No Abstract] [Full Text] [Related]
73. Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma.
Datta S; Dasgupta D; Ghosh A; Ghosh S; Manna A; Datta S; Chatterjee M; Chowdhury A; Banerjee S
Carcinogenesis; 2018 Feb; 39(2):283-292. PubMed ID: 29228221
[TBL] [Abstract][Full Text] [Related]
74. Interferon-stimulated gene 15 in hepatitis B-related liver diseases.
Hoan NX; Van Tong H; Giang DP; Toan NL; Meyer CG; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2016 Oct; 7(42):67777-67787. PubMed ID: 27626177
[TBL] [Abstract][Full Text] [Related]
75. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
76. Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.
Liu M; Du L; He Z; Yan L; Shi Y; Shang J; Tang H
Biomed Res Int; 2017; 2017():1252647. PubMed ID: 28373975
[No Abstract] [Full Text] [Related]
77. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
78. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
79. Fas antigen expression in liver tissues of patients with chronic hepatitis B.
Mochizuki K; Hayashi N; Hiramatsu N; Katayama K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1996 Jan; 24(1):1-7. PubMed ID: 8834017
[TBL] [Abstract][Full Text] [Related]
80. Signal transducer and activator of transcription 3 cooperates with androgen receptor/cell cycle-related kinase signalling pathway in the progression of hepatitis B virus infection and gender differences.
Xu Y; Qi W; Wang X; Zhang Y; Han L; Shi J; Wang G; Liu J; Duan H; Cong X; Zhao P; Zhou C; Wang J
J Viral Hepat; 2022 Jul; 29(7):569-578. PubMed ID: 35567395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
